2011 Annual Meeting | Neonatal Seizures: An Update
| 09:30 AM - 10:00 AM | Characterization, Classification, and Etiology of Neonatal Seizures Eli M. Mizrahi, MD, FAAN | |
| 09:30 AM - 11:30 AM | Break | |
| 10:00 AM - 10:35 AM | The Fetal and Neonatal Neurologic Evaluation Mark S. Scher, MD | |
| 10:35 AM - 11:10 AM | The Diagnosis and Anticonvulsant Treatment of Neonatal Seizures, Including Specific Metabolic Disorders James J. Riviello, Jr., MD | |
| 11:10 AM - 11:30 AM | Questions and Answers | 
| Eli M. Mizrahi, MD, FAAN | No disclosure on file | 
| James J. Riviello, Jr., MD | Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biomarin. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for J. Kiffin Penry Foundation. An immediate family member of Dr. Riviello has received publishing royalties from a publication relating to health care. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Utah. Dr. Riviello has received personal compensation in the range of $500-$4,999 for serving as a Visiting Professor with University of Calgary. | 
| Mark S. Scher, MD | Dr. Scher has nothing to disclose. |